← Leaderboards
Abhijit R. Patwardhan
University Of Kentucky
$883,268
Attributed
$1,444,479
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $379.6K · FY2019–21$500K$375K$250K$125K$0
'19
'20
'21
Funding mix
By agency
NIH$1,444,479 · 2
By mechanism
R01$1,444,479 · 2
Top collaborators
- Anthony P. Sinai3 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Erhard Bieberich$12,082,264
- Anthony P. Sinai$5,802,259
- David Stewart Watt$1,694,827
- Joan J Guinovart$705,752
- Berge A Minassian$2,734,249
Others in their field
Top investigators on “Dna Biosynthesis”
- Bruce W Stillman · Cold Spring Harbor Laboratory$21,030,410
- David K Cortez · Vanderbilt University$20,445,772
- Alanna Schepartz · Yale University$19,800,000
- Paul M. Lieberman · Wistar Institute$18,499,958
- Kenneth J Marians · Sloan-Kettering Institute For Cancer Res$17,895,080
- Yinsheng Wang · University Of California Riverside$17,788,669
Research focus
Dna BiosynthesisArchitectureAtovaquoneAcquired Immunodeficiency SyndromeBaroreflexBaseBehaviorBiologyAutomobile DrivingAmylopectinBudgetsCarbon DioxideCardiovascular FunctionCell Cycle ProgressionCell NucleusChronicChronic InfectionClinical ResearchComputer FrameworkBrainBrain CirculationCystCytoplasmic GranulesDrug Efficacy
Grant awards (6)
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$379,562
R01 · FY2021 · AI
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$374,141
R01 · FY2020 · AI
Quantitative Approaches for Drug Testing in Chronic Toxoplasmosis: Leveraging New Insights Into Bradyzoite Biology Within Tissue Cysts In Vivo$368,720
R01 · FY2019 · AI
Cardio-Respiratory Interaction: Contribution in Syncope$107,352
R01 · FY2003 · HL
Cardio-Respiratory Interaction: Contribution in Syncope$107,352
R01 · FY2002 · HL
Cardio-Respiratory Interaction: Contribution in Syncope$107,352
R01 · FY2001 · HL